4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001714899-22-000041
CFO and Treasurer sold 2,560 shares at $34.69 ($88,806)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Krognes Steve E. CFO and Treasurer | 2022-02-11 | Sale | −2,560 | $34.69 | $88,806 | 120,221 | D: show line 1 in the form |
| Open-market sales · 2,560 sh · avg $34.69 · $88,806 | |||||||
Loading xslF345X03/wf-form4_164496940391476.xml…